Cargando…
A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of Shenqisuxin granule in complex coronary artery disease after PCI: Study protocol
INTRODUCTION: The Shenqisuxin granule (SQSX), a novel Chinese herbal formula, has the effect of preventing in-stent restenosis and improving angiogenesis. We intend to evaluate the efficacy and safety of SQSX to provide a possible therapeutic strategy for complex coronary artery disease (CCAD) after...
Autores principales: | Wu, Xiaoping, Yan, Mingyu, Pang, Xingxue, Wu, Hui, Hu, Zhigeng, Xiao, Rui, Pan, Jianlue, Li, Ying, Shi, Shengnan, Deng, Yanping, Li, Jiaxi, Wang, Peili, Chen, Keji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575802/ https://www.ncbi.nlm.nih.gov/pubmed/36262203 http://dx.doi.org/10.3389/fcvm.2022.1000379 |
Ejemplares similares
-
Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial
por: Wu, Xiaoping, et al.
Publicado: (2022) -
The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol
por: Khan, Sarosh, et al.
Publicado: (2023) -
Optimising PCI by Intracoronary Image-guidance
por: Alasnag, Mirvat, et al.
Publicado: (2022) -
Prehospital and in-hospital delays to care and associated factors in patients with STEMI: an observational study in 101 non-PCI hospitals in China
por: Feng, Lin, et al.
Publicado: (2019) -
Long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI centre
por: Yao, Hai-Mu, et al.
Publicado: (2014)